SCHEMBL4843293

SCHEMBL4843293

COc1ccc(C(=O)c2ccc(F)cc2)c(C(=O)O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.60
MAPT P10636 4/20 0.58
HTT P42858 3/20 0.58
NPSR1 Q6W5P4 1/20 0.58
NPC1 O15118 4/20 0.56
LMNA P02545 2/20 0.54
CYP1A2 P05177 2/20 0.54
CYP2C19 P33261 2/20 0.54
PGR P06401 1/20 0.54
CYP2D6 P10635 1/20 0.54
HPGD P15428 1/20 0.54
SLC6A2 P23975 1/20 0.54
PDE4A P27815 1/20 0.54
MAPK1 P28482 1/20 0.54
HRH1 P35367 1/20 0.54
SLC6A3 Q01959 1/20 0.54
PDE4D Q08499 1/20 0.54
KMT2A Q03164 4/20 0.53
RAB9A P51151 4/20 0.53
MEN1 O00255 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4124832 0.91 NPC1 (0.68) ALDH1A1MAPTHTTNPSR1NPC1
SCHEMBL4838995 0.86 ALDH1A1 (0.66) ALDH1A1MAPTHTTNPSR1NPC1
SCHEMBL3480945 0.86 ALDH1A1 (0.71) ALDH1A1MAPTHTTNPSR1NPC1
SCHEMBL4842294 0.85 POLB (0.71) ALDH1A1MAPTHTTNPSR1NPC1
SCHEMBL4844039 0.85 MAPT (0.63) ALDH1A1MAPTHTTNPSR1NPC1
SCHEMBL20157807 0.84 NPC1 (0.59) ALDH1A1MAPTHTTNPSR1NPC1
SCHEMBL4456955 0.84 NPC1 (0.59) ALDH1A1MAPTHTTNPSR1NPC1
SCHEMBL4834450 0.84 ALDH1A1 (0.56) ALDH1A1MAPTHTTNPSR1NPC1
SCHEMBL3480570 0.84 NPC1 (0.55) ALDH1A1MAPTHTTNPSR1NPC1
SCHEMBL4833882 0.84 CDC25B (0.61) ALDH1A1MAPTHTTNPSR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423030-B2 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof SANOFI-AVENTIS (FR) 2008-09-09 US disclosed
US-20070099895-A1 1-AMINO-PHTHALAZINE DERIVATIVES, THE PREPARATION AND THE THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2007-05-03 US disclosed
CN-1953972-A 1-amino-phthalazine derivatives, their preparation and their therapeutic use SANOFI AVENTIS (FR) 2007-04-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099895-A1 1-AMINO-PHTHALAZINE DERIVATIVES, THE PREPARATION AND THE THERAPEUTIC USE THEREOF CYP11B2, CYP11B1, GOT2 ALDH1A1 86/4885MAPT 459/4885HTT 743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.